11:41:59 EDT Sun 03 Jul 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:INNPF from 2021-07-02 to 2022-07-01 - 40 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2022-06-24 16:01U:INNPFNews ReleaseInnocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: "It Was as If a New Dog Came into Our Lives"
2022-06-17 16:01U:INNPFNews ReleaseInnocan Pharma Announces Filing of PCT Patent Application for Vaginal Atrophy Treatment
2022-06-10 16:01U:INNPFNews ReleaseInnocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs
2022-05-30 16:01U:INNPFNews ReleaseInnocan Pharma Announces Q1 2022 Results with 215% Increase in Cash Balance and 200% Increase in Working Capital
2022-05-17 02:04U:INNPFNews ReleaseInnocan Pharma Obtains Receipt for Final Base Shelf Prospectus
2022-05-11 03:01U:INNPFNews ReleaseInnocan Pharma Announces the Successful Publication of a New Patent Application of Its New Sustained-Release (LPC) CBD Formulation
2022-04-29 03:01U:INNPFNews ReleaseInnocan Pharma's Compassionate Care Treatment for Dogs
2022-04-11 16:01U:INNPFNews ReleaseInnocan Pharma's Case Report Accepted to the 25M Readers of Frontiers Veterinary Scientific Journal
2022-03-28 16:01U:INNPFNews ReleaseInnocan Pharma Reports a Successful FDA-Required Characterization of Highly CBD-Loaded Liposome Platform
2022-03-08 16:01U:INNPFNews ReleaseInnocan Pharma Reports a Positive Result from the Use of Its CBD LPT on a Dog Suffering from Osteoarthritis
2022-03-04 03:01U:INNPFNews ReleaseFormer Beckman Coulter Dr. Eyal Kalo to join Innocan Pharma's Expanding R&D Team
2022-02-07 16:37U:INNPFNews ReleaseSony Ex-VP Dr. Kenji Kitatani to Join Innocan Pharma's Advisory Committee
2022-01-24 08:35U:INNPFNews ReleaseCannabis Industry Investor Presentations Now Available for On-Demand Viewing
2022-01-20 03:01U:INNPFNews ReleaseInnocan Pharma Announces Important Updates Regarding its LPT Platform Project and Commercialization Paths
2022-01-18 00:35U:INNPFNews ReleaseCannabis Industry Investor Conference: Company Executives Present January 19th & 20th
2022-01-17 16:01U:INNPFNews ReleaseInnocan Pharma Announces the Inauguration of Its Drug Development Lab at Biohouse in the Hadassah Medical Center in Jerusalem
2022-01-13 03:02U:INNPFNews ReleaseInnocan Pharma to Expand its LPT Platform to the Veterinary Field
2021-12-09 03:01U:INNPFNews ReleaseInnocan Announces the Execution of a Research & License Agreement with Ramot, the Technology Transfer Company of the Tel Aviv University for Cannabinoids Loaded Exosome Delivery Platform (CLX)
2021-11-18 16:01U:INNPFNews ReleaseInnocan Pharma Announces the Successful Demonstration of Prolonged Release of CDB in Dogs Using Its LPT Technology
2021-11-15 16:03U:INNPFNews ReleaseInnocan Pharma to Participate in the Lift & Co. Expo's Business Growth Panel on November 19th, 2021
2021-11-10 16:01U:INNPFNews ReleaseInnocan Pharma Reports Further Success in Profile Characterization Progress In Its micro-RNA Cannabinoids Loaded Exosome Delivery Platform (CLX) Project
2021-11-05 04:01U:INNPFNews ReleaseInnocan Pharma Announces 100% Exercise of Warrants Issued in December 2020 Private Placement
2021-10-28 02:01U:INNPFNews ReleaseInnocan Pharma CEO Iris Bincovich to Deliver a Speech at an Investor Gathering in Munich on October 29, 2021
2021-10-19 16:01U:INNPFNews ReleaseInnocan Reports of Presence of CBD in Mice's Brains 41 Days After Injection of CBD Using Innocan's Liposome Platform Technology
2021-10-13 19:09U:INNPFNews ReleaseInnocan Pharma Corporation Closes C$8.2 Million Private Placement with Institutional Investors
2021-10-08 08:51U:INNPFNews ReleaseInnocan Pharma Corporation Announces C$8.2 Million Private Placement with Institutional Investors
2021-10-04 16:13U:INNPFNews ReleaseInnocan Pharma Announces the Filing of a PCT Patent Application for its CBD Delivery System Technology in 153 Countries
2021-09-24 16:02U:INNPFNews ReleaseInnocan Pharma Announces the Filing by Ramot at Tel Aviv University of an International Patent Application for its Unique Cannabinoids Loaded Exosome Delivery Platform (CLX)
2021-09-13 08:43U:INNPFNews ReleaseCannabis Industry Investor Presentations Now Available for On-Demand Viewing
2021-09-13 07:32U:INNPFNews ReleaseCannabis Industry Investor Presentations Now Available for On-Demand Viewing
2021-09-03 16:02U:INNPFNews ReleaseInnocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals
2021-09-03 08:35U:INNPFNews ReleaseCannabis Executives Present: Cannabis Investor Conference September 8th & 9th
2021-09-02 08:35U:INNPFNews ReleaseCannabis Industry Investor Conference: Company Executives Present September 8th & 9th
2021-08-27 16:01U:INNPFNews ReleaseInnocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021
2021-08-18 03:01U:INNPFNews ReleaseInnocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University
2021-08-11 03:01U:INNPFNews ReleaseInnocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada
2021-08-03 02:55U:INNPFNews ReleaseInnocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)
2021-07-28 16:01U:INNPFNews ReleaseInnocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss
2021-07-14 03:05U:INNPFNews ReleaseFormer Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee
2021-07-09 16:03U:INNPFNews ReleaseInnocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms